United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$68Mraised across 5 rounds since 2002, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $9.4M sold, first sale May 2009
Domain Associates
Apax Partners
Split Rock Partners
Montreux Growth PartnersFrom a historical funding record
Domain AssociatesApax PartnersMontreux Growth Partners
St. Paul Venture CapitalFrom a historical funding record
From the SEC filings it signed: 5 on the team.
On the board, as filediAndrew N. SchiffBrian H. DoveyDavid F. HaleGeorge E. JenkinsGraham D.S. AndersonJames H. CavanaughRex D.S. BrightRichard E. FitzpatrickWilliam A. Roper
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Domain AssociatesApax PartnersHealthCare VenturesMontreux Growth PartnersPerseus-Soros Biopharmaceutical FundSplit Rock PartnersSt. Paul Venture CapitalEuclidSR PartnersWindamere Venture PartnersFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
This firm lists SkinMedica as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
SkinMedica's investors include Domain Associates, Apax Partners, HealthCare Ventures, Montreux Growth Partners and Perseus-Soros Biopharmaceutical Fund, and 4 more on record.
SkinMedica has raised $68M across 5 rounds since 2002.
SkinMedica's most recent round was a Venture of $9.4M in Jun 2009.
SkinMedica's largest round on record is $30M (Series D), in Jul 2004.
SkinMedica's first round on record, in Dec 2002, was backed by Domain Associates and Windamere Venture Partners.
SkinMedica's latest named round is a Venture, in Jun 2009.
SkinMedica is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
